Better Health at your fingertips

TARGETING MITOCHONDRIA

Mitochondria are pertinent targets for efficient drugs, cosmetics or functional food for better health and safer products. Find out how our tests can help advance your projects in demonstrating mechanisms of action and getting pre-clinical proof of principle.

Learn more about it
BLOOD MARKERS FOR DEMENTIA

ICDD is set to identify blood makers specifically for presymptomatic stages of neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington’s disease using cellulomics in innovative patient-derived cell models & blood protein profiling.

Learn more about it
PARTNER WITH US         

You have a drug that target CNS diseases and cancers. We have companion diagnostic tests and platforms to identify subset of patients that respond to and tolerate your drug. Let’s work together to advance patient health and disease clinical management.

Learn more about it
The Science of Possibility

HARNESSING THE POWER OF SYSTEM BIOLOGY

Understanding complex processes and their dynamics is how ICDD progresses toward the identification of new candidate biomarkers associated with disease progression and/or drug response.

EVENTS

AD/PD 2017 in Vienna
Come meet Nesrine Abboud at poster board # 271 to learn more about mitochondrial bioenergetics in PD and about ICDD's work on diagnostics for neurodegenerative diseases!
In‑Cosmetics London
Come see us on our stand DD53 to learn all about our technologies and services! Register before April 3rd for free show entry (save 60€).
AAIC 2017 in London
ICDD will attend the Alzheimer's Association International Conference! We look forward to meeting you there!

What we do

  • Disease modeling through mitochondrial dysfunction
  • Comprehensive assessment of cell metabolism in a multiplexed fashion
  • Assessment of mitochondrial liabilities
  • Identify whether ROS production is damageable in your system
  • Performances of mtDNA control
  • Selecting disease-modifying drugs for CNS
  • Profiling clinical tolerance at the pre-clinical stage
  • Personalized medicine diagnostic co-development
  • Molecular determinants of drug response & tolerance
  • They mention us

    Read our clients' and partners' publications (articles, white papers, websites, press releases, etc.) referring to the results obtained using ICDD's technologies and/or expertise.

  • Twendee by TIMA Japan
  • Biorevitalizing effect of a novel facial serum containing apple stem cell extract, pro-collagen lipopeptide, creatine, and urea on skin aging signs
  • They support us